Advertisement
Advertisement
CVRX
CVRx, Inc. Common Stock
0.87
USDSponsored
-0.60
-41.02%
Nov 06, 11:51 UTC -5
Open
CVRx, Inc. Common Stock (CVRX) Earnings
CVRX Earnings Reports
Positive Surprise Ratio
CVRX beat 13 of 22 last estimates.
59%
Next Report
Date of Next Report
Feb 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$14.75M
/-$0.49
Implied change from Q3 26 (Revenue/ EPS)
+6.64%
/-5.77%
Implied change from Q4 25 (Revenue/ EPS)
-7.96%
/+6.52%
CVRx, Inc. Common Stock earnings per share and revenue
On Nov 05, 2026, CVRX reported earnings of -0.52 USD per share (EPS) for Q3 26, missing the estimate of -0.50 USD, resulting in a -2.91% surprise. Revenue reached 13.83 million, compared to an expected 14.22 million, with a -2.74% difference.
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.49 USD, with revenue projected to reach 14.75 million USD, implying an decrease of -5.77% EPS, and increase of 6.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
FAQ
What were CVRx, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, CVRx, Inc. Common Stock reported EPS of -$0.52, missing estimates by -2.91%, and revenue of $13.83M, -2.74% below expectations.
How did the market react to CVRx, Inc. Common Stock's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is CVRx, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 10, 2027.
What are the forecasts for CVRx, Inc. Common Stock's next earnings report?
Based on --
analysts, CVRx, Inc. Common Stock is expected to report EPS of -$0.49 and revenue of $14.75M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.